Indivior PLC Announces LTIP Awards to Key Executives
Why we think this is neutral
This RNS is a routine regulatory announcement regarding the grant of Conditional Awards under Indivior's Long-Term Incentive Plan to several key executives. The details provided are standard for this type of announcement, and there are no obvious positive or negative factors that would significantly impact the company's performance or investor sentiment.
Key Points
- Indivior PLC granted Conditional Awards over Ordinary Shares under the 2024 LTIP to key executives
- Vesting is subject to continued employment and achievement of performance conditions
- Performance conditions include relative Total Shareholder Return, US Sublocade market share, and Long-acting Injectables category growth
Summary
Indivior PLC, a specialty pharmaceutical company, has announced the grant of Conditional Awards over Ordinary Shares under the Indivior 2024 Long-Term Incentive Plan (LTIP) to its key executives. The vesting of these awards is subject to the rules of the LTIP, continued employment, and the achievement of performance conditions based on relative Total Shareholder Return, the US Sublocade share of the Long-acting Injectables category, and Long-acting Injectables category growth.